CD Protein Inhibitors 

  Products    Products    Diseases    News 

12345678910111213...2728»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02745488221096137016441918219224662740
            
            
             
Rituxan (rituximab) / Roche           
          
            
             
Keytruda (pembrolizumab) / Merck (MSD)           
          
            
             
Opdivo (nivolumab) / BMS           
          
            
             
AiRuiKa (camrelizumab) / HLB Bio Group           
          
            
             
Tecentriq (atezolizumab) / Roche           
          
            
             
Imfinzi (durvalumab) / AstraZeneca           
          
            
             
Tyvyt (sintilimab) / Eli Lilly           
          
            
             
Tevimbra (tislelizumab) / BeiGene           
          
            
             
sunitinib / Generic mfg.           
          
            
             
Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci           
          
            
             
Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap           
          
            
             
Ibrance (palbociclib) / Pfizer           
          
            
             
Campath (alemtuzumab) / Sanofi           
          
            
             
Bavencio (avelumab) / EMD Serono           
          
            
             
Gazyva (obinutuzumab) / Roche, Biogen, Nippon Shinyaku           
          
            
             
Orencia (abatacept) / BMS           
          
            
             
Darzalex (daratumumab) / J&J           
          
            
             
Verzenio (abemaciclib) / Eli Lilly           
          
            
             
Promacta (eltrombopag) / Novartis           
          
            
             
Adcetris (brentuximab vedotin) / Takeda, Pfizer           
          
            
             
Kisqali (ribociclib) / Novartis           
          
            
             
Kaitanni (cadonilimab) / Akesobio           
          
            
             
Libtayo (cemiplimab-rwlc) / Regeneron           
          
            
             
Simulect (basiliximab) / Novartis           
          
            
             
Arzerra (ofatumumab) / Novartis, Genmab           
          
            
             
Mylotarg (gemtuzumab ozogamicin) / UCB, PDL, Pfizer           
          
            
             
Blincyto (blinatumomab) / Astellas, Amgen           
          
            
             
Zevalin (ibritumomab tiuxetan) / Servier, Aurobindo           
          
            
             
Ocrevus (ocrelizumab) / Roche, Biogen           
          
            
             
Darzalex Faspro (daratumumab/hyaluronidase) / J&J           
          
            
             
adebrelimab (SHR-1316) / Jiangsu Hengrui Pharma           
          
            
             
AiRuiKang (dalpiciclib) / Jiangsu Hengrui Pharma           
          
            
             
Sarclisa (isatuximab-irfc) / Sanofi           
          
            
             
Anniko (penpulimab) / Akesobio, Sino Biopharm           
          
            
             
Enweida (envafolimab) / 3DMed, Tracon Pharma, Ascletis           
          
            
             
Zinbryta (daclizumab) / Biogen, AbbVie           
          
            
             
Hansizhuang (serplulimab) / Fosun Pharma           
          
            
             
Jemperli (dostarlimab-gxly) / GSK           
          
            
             
Nulojix (belatacept) / BMS           
          
            
             
Nplate (romiplostim) / Amgen, Kyowa Kirin           
          
            
             
Yutuo (zimberelimab) / Arcus Biosci, Gilead           
          
            
             
Hengqu (hetrombopag) / Jiangsu Hengrui Pharma           
          
            
             
Doptelet (avatrombopag) / SOBI           
          
            
             
Polivy (polatuzumab vedotin-piiq) / Roche           
          
            
             
spartalizumab (PDR001) / Novartis           
          
            
             
alvocidib (DSP-2033) / Sumitomo Pharma           
          
            
             
bintrafusp alfa (M7824) / EMD Serono           
          
            
             
Zynyz (retifanlimab-dlwr) / Incyte           
          
            
             
Besponsa (inotuzumab ozogamicin) / Pfizer, UCB           
          
            
             
benmelstobart (APL-502) / Apollomics           
          
            
            


12345678910111213...2728»